©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Hepatol. Aug 27, 2021; 13(8): 896-903
Published online Aug 27, 2021. doi: 10.4254/wjh.v13.i8.896
Published online Aug 27, 2021. doi: 10.4254/wjh.v13.i8.896
Solid pseudopapillary neoplasm of the pancreas
Ayo O Omiyale, Department of Cellular Pathology, Imperial College Healthcare NHS Trust, Charing Cross Hospital, London W6 8RF, United Kingdom
Author contributions: Omiyale AO reviewed the literature and wrote the manuscript.
Conflict-of-interest statement: The author declares no conflict of interest for this article.
Corresponding author: Ayo O Omiyale, MBChB, MPH, Doctor, Department of Cellular Pathology, Imperial College Healthcare NHS Trust, Charing Cross Hospital, Fulham Palace Road, London W6 8RF, United Kingdom. ayodeji.omiyale@nhs.net
Received: March 2, 2021
Peer-review started: March 2, 2021
First decision: May 2, 2021
Revised: May 16, 2021
Accepted: August 3, 2021
Article in press: August 3, 2021
Published online: August 27, 2021
Processing time: 170 Days and 16.9 Hours
Peer-review started: March 2, 2021
First decision: May 2, 2021
Revised: May 16, 2021
Accepted: August 3, 2021
Article in press: August 3, 2021
Published online: August 27, 2021
Processing time: 170 Days and 16.9 Hours
Core Tip
Core Tip: Solid pseudopapillary neoplasms are low-grade malignant tumours that mimic other solid cellular neoplasms of the pancreas. This article summarizes the clinical and pathologic features of solid pseudopapillary neoplasm of the pancreas including the epidemiology, molecular pathology, differential diagnosis, treatment, and prognosis.
